Pluto Bio Raises $3.6M to Expand AI-Powered Multi-Omics Analysis Platform for Pharma
Pluto Bio, the leading, AI-powered platform for computational biology, today announced it has raised $3.6 million in new funding to accelerate growth and scale adoption of its enterprise-grade platform among global pharma companies. The round includes participation from new investor Kickstart, alongside existing investor Silverton Partners and existing angel investors.
